SK11062003A3 - Nové kyanosubstituované dihydropyrimidínové zlúčeniny a ich použitie na liečenie chorôb - Google Patents
Nové kyanosubstituované dihydropyrimidínové zlúčeniny a ich použitie na liečenie chorôb Download PDFInfo
- Publication number
- SK11062003A3 SK11062003A3 SK1106-2003A SK11062003A SK11062003A3 SK 11062003 A3 SK11062003 A3 SK 11062003A3 SK 11062003 A SK11062003 A SK 11062003A SK 11062003 A3 SK11062003 A3 SK 11062003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- cyano
- oxo
- dihydro
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27995601P | 2001-03-29 | 2001-03-29 | |
| PCT/US2002/009497 WO2002079149A2 (en) | 2001-03-29 | 2002-03-26 | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK11062003A3 true SK11062003A3 (sk) | 2004-08-03 |
Family
ID=23071059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1106-2003A SK11062003A3 (sk) | 2001-03-29 | 2002-03-26 | Nové kyanosubstituované dihydropyrimidínové zlúčeniny a ich použitie na liečenie chorôb |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6809102B2 (hu) |
| EP (1) | EP1373221A4 (hu) |
| JP (1) | JP2005504725A (hu) |
| KR (1) | KR20030086327A (hu) |
| CN (1) | CN1507435A (hu) |
| AR (1) | AR034585A1 (hu) |
| BG (1) | BG108180A (hu) |
| BR (1) | BR0208405A (hu) |
| CA (1) | CA2442482A1 (hu) |
| CZ (1) | CZ20032645A3 (hu) |
| EE (1) | EE200300474A (hu) |
| HR (1) | HRP20030875A2 (hu) |
| HU (1) | HUP0400350A3 (hu) |
| IL (1) | IL157441A0 (hu) |
| IS (1) | IS6967A (hu) |
| MX (1) | MXPA03008634A (hu) |
| NO (1) | NO20034300L (hu) |
| PE (1) | PE20021013A1 (hu) |
| PL (1) | PL373759A1 (hu) |
| RU (1) | RU2003130961A (hu) |
| SK (1) | SK11062003A3 (hu) |
| TW (1) | TWI228416B (hu) |
| UY (1) | UY27232A1 (hu) |
| WO (1) | WO2002079149A2 (hu) |
| YU (1) | YU75803A (hu) |
| ZA (2) | ZA200306648B (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6900214B2 (en) * | 2001-03-29 | 2005-05-31 | Bristol-Myers Squibb Company | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| EP1454903B9 (en) * | 2001-12-11 | 2011-10-05 | Kyowa Hakko Kirin Co., Ltd. | Thiadiazoline derivatives for treating cancer |
| MY141583A (en) * | 2003-03-07 | 2010-05-14 | Astrazeneca Ab | Novel fused heterocycles and uses thereof |
| WO2006018628A1 (en) * | 2003-03-07 | 2006-02-23 | Astrazeneca Ab | Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| ATE537158T1 (de) | 2003-04-18 | 2011-12-15 | Kyowa Hakko Kirin Co Ltd | M-stage-kinesin-inhibitor |
| WO2004111024A1 (ja) * | 2003-06-10 | 2004-12-23 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン誘導体 |
| US7157461B2 (en) | 2003-07-23 | 2007-01-02 | Bristol-Myers Squibb Co. | Substituted dihydropyrimidine inhibitors of calcium channel function |
| US7166603B2 (en) | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
| JP2007509074A (ja) * | 2003-10-16 | 2007-04-12 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
| CN101023082A (zh) * | 2004-07-22 | 2007-08-22 | 阿斯利康(瑞典)有限公司 | 用于治疗和预防癌症的稠合嘧啶酮类 |
| JP2008509977A (ja) * | 2004-08-18 | 2008-04-03 | アストラゼネカ アクチボラグ | 癌の処置及び予防における選択された縮合複素環の鏡像異性体及びその使用 |
| US20060041128A1 (en) * | 2004-08-18 | 2006-02-23 | Astrazeneca Ab | Selected fused heterocyclics and uses thereof |
| WO2006060737A2 (en) * | 2004-12-03 | 2006-06-08 | Takeda San Diego, Inc. | Mitotic kinesin inhibitors |
| CN101193878A (zh) * | 2005-03-22 | 2008-06-04 | 协和发酵工业株式会社 | 实体肿瘤治疗剂 |
| WO2006101103A1 (ja) * | 2005-03-22 | 2006-09-28 | Kyowa Hakko Kogyo Co., Ltd. | 造血器腫瘍治療剤 |
| WO2006137490A1 (ja) * | 2005-06-24 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | 再狭窄治療剤 |
| DE102006002065B4 (de) * | 2006-01-16 | 2007-11-29 | Infineon Technologies Austria Ag | Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand |
| CN110464722B (zh) * | 2019-06-06 | 2023-05-23 | 暨南大学 | 一类小分子化合物或其药学上可接受的盐在制备抗肿瘤转移药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6211198B1 (en) | 1993-04-05 | 2001-04-03 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| EE9700209A (et) | 1994-11-16 | 1998-04-15 | Synaptic Pharmaceutical Corporation | Dihüdropürimidiinid ja nende kasutamine |
| WO1997017969A1 (en) | 1995-11-16 | 1997-05-22 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
| JP2000506904A (ja) | 1996-05-16 | 2000-06-06 | シナプティック・ファーマスーティカル・コーポレーション | ジヒドロピリミジン類およびその使用 |
| US6172066B1 (en) | 1996-05-16 | 2001-01-09 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
| US6080760A (en) | 1997-06-18 | 2000-06-27 | Merck & Co., Inc. | Alpha 1A adrenergic receptor antagonists |
| WO1998057639A1 (en) | 1997-06-18 | 1998-12-23 | Merck & Co., Inc. | ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS |
| AU1403099A (en) | 1997-11-14 | 1999-06-07 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
| WO1999050440A2 (en) | 1998-04-01 | 1999-10-07 | Yale University | Method to identify modulators of survivin - tubulin interaction |
| US6300084B1 (en) | 1998-10-08 | 2001-10-09 | The Regents Of The University Of California | Anti-mitotic agent screening process |
| AUPQ171999A0 (en) | 1999-07-20 | 1999-08-12 | University Of Sydney, The | Neurotropic virus transport |
| DE19935303A1 (de) | 1999-07-28 | 2001-02-08 | Aventis Pharma Gmbh | Oligonukleotide zur Inhibierung der Expression von humanem eg5 |
| US6617115B1 (en) | 1999-10-27 | 2003-09-09 | Cytokinetics, Inc. | Methods of screening for modulators of cell proliferation |
| BR0015110A (pt) | 1999-10-27 | 2002-07-02 | Cytokinetics Inc | Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos |
| US6284480B1 (en) | 2000-04-03 | 2001-09-04 | Cytokinetics, Inc. | Antifungal assay |
| US6900214B2 (en) | 2001-03-29 | 2005-05-31 | Bristol-Myers Squibb Company | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
-
2002
- 2002-03-22 US US10/104,257 patent/US6809102B2/en not_active Expired - Lifetime
- 2002-03-25 PE PE2002000232A patent/PE20021013A1/es not_active Application Discontinuation
- 2002-03-25 TW TW091105771A patent/TWI228416B/zh not_active IP Right Cessation
- 2002-03-26 WO PCT/US2002/009497 patent/WO2002079149A2/en active Search and Examination
- 2002-03-26 HU HU0400350A patent/HUP0400350A3/hu unknown
- 2002-03-26 RU RU2003130961/04A patent/RU2003130961A/ru not_active Application Discontinuation
- 2002-03-26 BR BR0208405-8A patent/BR0208405A/pt not_active IP Right Cessation
- 2002-03-26 PL PL02373759A patent/PL373759A1/xx not_active Application Discontinuation
- 2002-03-26 SK SK1106-2003A patent/SK11062003A3/sk unknown
- 2002-03-26 EE EEP200300474A patent/EE200300474A/xx unknown
- 2002-03-26 CA CA002442482A patent/CA2442482A1/en not_active Abandoned
- 2002-03-26 YU YU75803A patent/YU75803A/sh unknown
- 2002-03-26 EP EP02728592A patent/EP1373221A4/en not_active Withdrawn
- 2002-03-26 KR KR10-2003-7012604A patent/KR20030086327A/ko not_active Application Discontinuation
- 2002-03-26 CN CNA028074556A patent/CN1507435A/zh active Pending
- 2002-03-26 MX MXPA03008634A patent/MXPA03008634A/es unknown
- 2002-03-26 IL IL15744102A patent/IL157441A0/xx unknown
- 2002-03-26 JP JP2002577776A patent/JP2005504725A/ja not_active Withdrawn
- 2002-03-26 CZ CZ20032645A patent/CZ20032645A3/cs unknown
- 2002-03-27 UY UY27232A patent/UY27232A1/es not_active Application Discontinuation
- 2002-03-27 AR ARP020101168A patent/AR034585A1/es unknown
-
2003
- 2003-08-26 ZA ZA200306648A patent/ZA200306648B/en unknown
- 2003-09-17 BG BG108180A patent/BG108180A/xx unknown
- 2003-09-18 ZA ZA200307320A patent/ZA200307320B/en unknown
- 2003-09-24 IS IS6967A patent/IS6967A/is unknown
- 2003-09-26 NO NO20034300A patent/NO20034300L/no not_active Application Discontinuation
- 2003-10-28 HR HR20030875A patent/HRP20030875A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005504725A (ja) | 2005-02-17 |
| WO2002079149A2 (en) | 2002-10-10 |
| UY27232A1 (es) | 2002-11-29 |
| NO20034300D0 (no) | 2003-09-26 |
| AR034585A1 (es) | 2004-03-03 |
| CN1507435A (zh) | 2004-06-23 |
| US6809102B2 (en) | 2004-10-26 |
| MXPA03008634A (es) | 2003-12-08 |
| HUP0400350A2 (hu) | 2005-01-28 |
| NO20034300L (no) | 2003-11-07 |
| ZA200306648B (en) | 2004-11-26 |
| PE20021013A1 (es) | 2002-11-10 |
| HUP0400350A3 (en) | 2005-06-28 |
| RU2003130961A (ru) | 2005-04-10 |
| BR0208405A (pt) | 2004-03-30 |
| TWI228416B (en) | 2005-03-01 |
| CA2442482A1 (en) | 2002-10-10 |
| PL373759A1 (en) | 2005-09-05 |
| KR20030086327A (ko) | 2003-11-07 |
| EP1373221A2 (en) | 2004-01-02 |
| IL157441A0 (en) | 2004-03-28 |
| CZ20032645A3 (cs) | 2004-06-16 |
| YU75803A (sh) | 2006-05-25 |
| WO2002079149A3 (en) | 2003-02-27 |
| EE200300474A (et) | 2003-12-15 |
| BG108180A (en) | 2004-09-30 |
| IS6967A (is) | 2003-09-24 |
| US20030008888A1 (en) | 2003-01-09 |
| HRP20030875A2 (en) | 2004-08-31 |
| EP1373221A4 (en) | 2004-09-29 |
| ZA200307320B (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6809102B2 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| US6900214B2 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| JP4394442B2 (ja) | 抗炎症剤として有用なスピロ−ヒダントイン化合物 | |
| CA2701150C (fr) | Derives de quinazolinedione, leur preparation et leurs applications therapeutiques | |
| AU2002249389B2 (en) | Inhibitors of cyclin dependent kinases as anti-cancer agent | |
| US20020165240A1 (en) | Method of treating proliferative diseases using Eg5 inhibitors | |
| ZA200106584B (en) | Triazole compounds with dopamine-D3-receptor affinity. | |
| KR20060072142A (ko) | Ｃｒｆ 길항제 및 이환식 복소환 화합물 | |
| AU2003295396A1 (en) | Heteroaryl-pyramidine derivatives as jak inhibitors | |
| KR20090115749A (ko) | 우레이드기와 아미노카르보닐기를 치환기로서 갖는 신규 피롤 유도체 | |
| AU2014234907B2 (en) | Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
| KR20190027383A (ko) | 아폽토시스 억제제 | |
| JP2002544272A (ja) | 置換３−ピリジル−４−アリールピロール並びに関連した治療及び予防法 | |
| AU2002258636A1 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| AU2002303169A1 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| US4343801A (en) | 1,2,4-Triazine derivatives, and their production and use | |
| KR20190139640A (ko) | AIMP2-DX2와 K-Ras의 결합을 저해하는 화합물을 포함하는 고형암 예방 또는 치료용 조성물 및 AIMP2-DX2와 K-Ras의 결합을 저해하는 신규 화합물 | |
| CA2161436A1 (en) | Antiproliferative naphthyridines | |
| CA3002875A1 (en) | Pyridone derivatives and their use as kinase inhibitors | |
| WO2023212239A1 (en) | Compositions useful for modulating splicing | |
| Mohareb et al. | Heterocyclic synthesis with ethyl α‐(3‐carbamoyl‐4, 5, 6, 7‐tetrahydrobenzo [b] thiophen‐2‐ylhydrazono) acetates: An expeditious synthetic approach to polyfunctionally substituted pyran, pyridine, and pyridazine derivatives | |
| AU2002248724A1 (en) | A method of treating proliferative diseases using Eg5 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB9A | Suspension of patent application procedure |